Cearvol Wave vs Resound Vivia 9 60S microRIE

The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. The Wave's standout performance is in music streaming, where it scores a strong 4.1/5—a full 2.18 points above the OTC category average. This makes it an unusually capable choice for users who prioritize audio entertainment alongside speech amplification. Speech performance is solid in quiet environments at 3.1/5, sitting 0.36 points above the category average. Speech in noise presents a more mixed picture: while the 2.0/5 score exceeds the category average by 0.56 points, it remains modest in absolute terms—typical of OTC devices without advanced noise management. Own-voice comfort scores 2.1/5, falling 0.41 points below average, which may be noticeable during extended wear. Feedback handling is solid at 3.8/5, though 0.74 points below the category average. The Cearvol Wave is best suited for budget-conscious consumers who want capable music streaming and adequate speech clarity in quieter settings. Those frequently in noisy environments or sensitive to own-voice quality may want to consider alternatives with stronger performance in those areas.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.